The effects of different levels of quercetin on the blood pressure were studied in 6-week-old male Sprague-Dawley rats. The rats were fed with a control diet or a high-fat high-sucrose (HFS) diet containing 0, 0.02, 0.07, 0.2, or 0.5% quercetin for 4 weeks. The systolic blood pressure and the lipid peroxides in the plasma were both higher in the rats fed with the HFS diet without quercetin than in the rats fed with the control diet. The nitric oxide synthase (NOS) activity in the vascular tissues and nitric oxide (NO) metabolites in the plasma and urine were both lower in these rats. A distinct depression of the increase in blood pressure was found in the rats fed with the HFS diets containing quercetin. Each level of quercetin examined was effective, the 0.5% level being much more effective than other levels. Dietary quercetin decreased lipid peroxidation in the plasma of the rats fed with the HFS diets. Quercetin also suppressed the decrease in NO metabolites in the plasma and urine, and the NOS activity in the vascular tissues of these rats. These results suggest that the increased NO availability caused by the elevated NOS activity, and the antioxidative activity in these rats fed with quercetin may be sources of the antihypertensive effect of quercetin.
It is well known that a diet high in saturated fat and refined-carbohydrate (sucrose) leads to hyperlipidemia and hypercholesterolemia, and increases the risk of cardiovascular disease. Several recent studies have shown that the consumption of a high-fat or high-fat high-sucrose (HFS) diet induced a significant rise in the arterial blood pressure of normotensive rats. [1] [2] [3] The hypertensive effects of the HFS diet were accompanied by oxidative stress, 1, 3) but the role of oxidative stress in the genesis and maintenance of hypertension is not yet fully understood. This type of hypertension is a model for life-style related disease, and another type of hypertension is the spontaneously hypertensive rat (SHR), this being a model for essential hypertension. In the case of SHR, the importance of oxidative stress on the development of hypertension was evident from experiments involving the administration of many kinds of antioxidant [4] [5] [6] [7] [8] with consequent lowering of the hypertension.
The endothelium-derived relaxing factor, nitric oxide (NO), is produced from arginine by NO synthase (NOS) activity, and is responsible for acetylcholine-mediated vascular relaxation. Several recent studies have suggested a link between high-fat mediated oxidative stress and decreased NOS activity in hyperlipidemic animals 9, 10) and isolated rat hepatocytes. 11) These results suggest that the reduced NOS activity and subsequent decreased NO concentration might lead to an elevated blood pressure.
Quercetin is the most abundant of the flavonol-type flavonoids in fruits and vegetables. A wide range of biological actions of quercetin, including vasodilation and antithrombotic effects, has been reported. 12, 13) The effects of quercetin on blood pressure have been studied less extensively. We have found only one report on the antihypertensive effects of quercetin on SHR, 14) but details of this effect were not presented. Furthermore, no such report has been found on normotensive rats. Quercetin is also well known to have in vitro 15, 16) and in vivo 17, 18) antioxidative effects. However, we have not found any information on the effects of quercetin on the NOS activity in vascular tissues of rats fed with an HFS diet.
Our present work examines the effects of dietary quercetin added at various levels (0.02, 0.07, 0.2 or 0.5%) on the hypertensive status of rats fed with an HFS diet to elucidate the effect of quercetin on life-stylerelated hypertension. The effects of quercetin on the oxidative status and NOS activity are also reported.
Materials and Methods
Animals and experimental diet. Forty-nine 6-week-old male Sprague-Dawley rats were obtained from SLC Japan (Hamamatsu, Japan), and were separated into two groups of 21 and 28 rats each for experiments 1 and 2, respectively. The animals were housed individually in cages with wire mesh bottoms in a room kept at 22 AE 1 C and with a 12:12-h light:dark cycle (a light period from 8:00 to 20:00 h). The animals were given free access to water and a basal diet for the first 4 or 5 days, and were subsequently randomly divided into test groups of seven animals each with similar average values for the initial body weight and systolic blood pressure. In experiment 1, one group received a control diet (Control group), and the other two groups were fed with a high-fat high-sucrose (HFS) diet containing none or 0.2% of quercetin (HFS and 0.2Q groups). In experiment 2, four groups were fed with an HFS diet containing none, 0.02, 0.07, or 0.5% of quercetin (HFS, 0.02Q, 0.07Q, and 0.5Q groups). The composition of the basal diet was as follows (wt %): corn oil, 5.0; mineral mixture, 3.5; vitamin mixture, 1.0; choline bitartrate, 0.25; casein, 20.0; cellulose, 5.0; and corn -starch to make 100. The composition of the HFS diet was as follows (wt %): corn oil, 5.0; lard, 15.0; cholesterol, 0.5; mineral mixture, 3.5; vitamin mixture, 1.0; choline bitartrate, 0.25; casein, 20.0; sucrose, 40.0; cellulose, 5.0; and corn -starch to make 100. The composition of the quercetin diet was similar to the HFS diet, except that 0.02, 0.07, 0.2, or 0.5% of the cellulose was replaced with quercetin. Quercetin was purchased from Wako Pure Chemicals Co., Ltd. (Osaka, Japan). The composition of the mineral mixture was AIN-93G-MX and that of the vitamin mixture was AIN-93-VX. 19) Food and water were given ad libitum for the 4-week duration of the experiment. All experiments were done under the Ethics Guidelines for Animal Experiments of Osaka City University.
Sampling procedures. After the 4-week growing period, the rats were starved overnight, anesthetized, and their blood was collected in a heparinized syringe from the abdominal aorta. The plasma was separated by centrifugation at 1;000 Â g and 4 C for 15 min. A portion of the plasma was used to measure the lipid peroxide, and the rest was stored at À80 C while awaiting a biochemical analysis. Immediately after blood sampling, the thoracic aorta was taken out, rinsed gently with chilled saline, blotted, and stored at À80 C while awaiting an analysis of the nitric oxide synthase (NOS) activity. Urine was collected during the last 3 days of the growing period with the rats placed in stainless steel metabolic cages.
Blood pressure. The systolic blood pressure was measured at the start and at the end of the 2-and 4-week feeding periods by the tail-cuff method 20) with a BP98 instrument (Softron, Japan).
Lipid concentration in the plasma. The concentrations of total cholesterol and triacylglycerol in the plasma were determined by enzymatic colorimetric tests with commercial diagnostic kits (cholesterol CII-test and triglyceride G-test, respectively) from Wako Pure Chemicals.
Lipid peroxides in the plasma. Lipid peroxides in the blood plasma were measured as thiobarbituric acid reactive substances (TBARS) by the spectrometric method 21) and are expressed as the amount of malondialdehyde (MDA) in the plasma.
Nitric oxide (NO) metabolites in the urine and plasma. The total nitrate and nitrite concentrations in the urine and plasma were measured by reacting with the Greiss reagent according to the procedure described by Wu et al. 22) The NO metabolites excreted in the urine are expressed as total nitrate and nitrite per creatinine in the urine. Creatinine excreted in the urine was determined by using a commercial diagnostic kit (creatininetest) from Wako Pure Chemicals.
NOS activity in the aorta. NOS activity was measured by the method of Bredt and Snyder.
23) The abdominal aorta were homogenized with five volumes of 50 mM HEPES (pH 7.4) containing 1 mM dithiothreitol, 1 mM EDTA, 5 mg/ml of phenylmethylsulphonyl fluoride, 5 mg/ml of pepstatin and 5 mg/ml of aprotinine. The homogenate was centrifuged for 5 min at 11;000 Â g, and the resulting supernatant was used for the NOS assays. The assay mixture consisted of 12.5 mM HEPES (pH 7.3), 1.2 mM MgCl 2 , 0.96 mM CaCl 2 , 3 mM tetrahydrobiopterin,
14 C]arginine (1.5 kBq), 0.12 mM NADPH, and 0.02 ml of the homogenate supernatant in a final volume of 0.1 ml. The NOS activity is expressed as the amount of citrulline produced per protein. Protein was determined by the method of Lowry et al.
24)
Statistical analysis. Each data value for the animal experiments is expressed as the mean AE SEM of seven rats. Data were subjected to an analysis of variance (oneway ANOVA) and multiple-range comparison by Fisher's protected least significant difference (PLSD) procedure by using StatView (Abacus Concepts, Berkeley, CA, USA). A P value of <0:05 is considered significantly different.
Results
Growth, dietary intake, and lipids in the plasma In experiment 1, the body weight gain and food efficiency in the HFS group were higher than those of the control group (Table 1 , experiment 1). The body weight gain and food intake of the 0.2Q group were no different from those of the HFS group, but the food efficiency of the 0.2Q group was lower than that of the HFS group. The epididymal fat weight and total cholesterol in the plasma from the HFS and 0.2Q groups were higher than those from the control group, the figures for the 0.2Q group being no different from the HFS group. Triacylglycerol in the plasma from the 0.2Q group was no different from that from the HFS group. In experiment 2, the body weight gain of the 0.5Q group was lower than that of the HFS, 0.02Q, and 0.07Q groups ( Table 1 , experiment 2). The food intake and food efficiency of the 0.02Q, 0.07Q, and 0.5Q groups were no different from those of the HFS group. The epididymal fat weight of the 0.5Q group was lower than that of the HFS, 0.02Q, and 0.07Q groups. Total cholesterol and triacylglycerol in the plasma from these four groups were no different from each other.
Systolic blood pressure
The systolic blood pressure of the rats in the HFS group was higher than that in the control group at 2 and 4 weeks, and the pressure of the rats in the 0.2Q group was lower than that in the HFS group at 2 and 4 weeks ( Table 2 , experiment 1). The systolic blood pressure of the rats in the 0.02Q, 0.07Q, and 0.5Q groups was lower than that in the HFS group at 2 and 4 weeks. The effect on the 0.5Q group of suppressing the increase in blood pressure was stronger than that on the 0.02Q and 0.07Q groups at 4 weeks (Table 2, experiment 2). As shown in Fig. 1 , quercetin added to the diet was concentration-dependently effective for suppressing the increase in blood pressure of the rats fed with the highfat high-sucrose diet.
NO metabolites in the plasma and urine
In respect of the plasma, the concentration of NO metabolites in the HFS group was significantly lower than that in the control group, and the value in the 0.2Q group was similar to that in the control group (Fig. 2,  experiment 1 ). This concentration in the 0.02Q and 0.07Q groups was significantly higher than that in the HFS group, the value in the 0.5Q group being higher than that in the 0.02Q and 0.07Q groups (Fig. 2,  experiment 2) .
In respect of the urine, the excreted amount of NO metabolites in the HFS group was significantly lower than that in the control group, the value in the 0.2Q The decrease in blood pressure from the HFS group (calculated from the data at 4 weeks in Table 1 ) is plotted against the dietary quercetin concentration.
group being similar to that in the control group (Fig. 3,  experiment 1) . The values in the 0.02Q and 0.07Q groups were significantly higher than that in the HFS group, while the value in the 0.5Q group was higher than that in the 0.02Q and 0.07Q groups (Fig. 3,  experiment 2 ).
NOS activity in the aorta
The NOS activity in the aorta of the HFS group was significantly lower than that of the control group, this activity of the 0.2Q group being higher, but not significantly, than that of the HFS group (Fig. 4,  experiment 1 ). The activity of the 0.02Q and 0.07Q groups was higher, but not significantly, than that of the HFS group, the value for the 0.5Q group being significantly higher than that for the HFS, 0.02Q and 0.07Q groups (Fig. 4, experiment 2 ).
Lipid peroxides in the plasma
In experiment 1, the TBARS value in the plasma was higher in the rats of the HFS group than of the control group, and the value for the 0.2Q group was lower than that for the HFS group (Fig. 5) . In experiment 2, the TBARS value in the plasma from the 0.5Q group, but not that from the 0.02Q or 0.07Q group, was significantly lower than that from the HFS group.
Discussion
Current interest in health foods has spurred studies on the hypolipidemic and hypocholesterolemic effects of food components. Quercetin and other flavonoids have been shown to inhibit cholesterol biosynthesis in hepatic cells. 25) The inhibitory effects of quercetin on fatty acid synthase activity have also been shown in an in vitro experiment. 26) In this present experiment, no effect of quercetin on decreasing triacylglycerol and cholesterol in the plasma was apparent in the rats fed with the highfat high-sucrose diet. These results suggest that quercetin had no significant hypolipidemic effect when added to the diet at a concentration of less than 0.5%.
Although a wide range of biological effects of quercetin has been reported in previous studies, only a few reports were found on the antihypertensive effects of quercetin. Duarte et al. have shown antihypertensive effects of quercetin on SHR by orally dosing, 14) but no report was found on normotensive rats. In the present experiment, we found that quercetin suppressed the increase in blood pressure and lipid peroxidation in normotensive rats fed with the high-fat high-sucrose diets. The effective dietary levels of quercetin were 0.02, 0.07, 0.2, and 0.5%, the level of 0.5% being much more effective than the other levels. A significant rise in blood pressure was accompanied with enhanced oxidation in the rats fed with the high-fat high-sucrose diet. These results suggest a probable role of oxidative stress on the genesis and maintenance of hypertension. Oxidative stress may contribute to hypertension via several mechanisms. Superoxide is known to react quickly with NO, 27) and its consequent deactivation of NO is responsible for the retardation of acetylcholine-mediated vascular relaxation. In this present experiment, the operation of such a mechanism is supported by the results that the level of NO metabolites in the plasma and urine was significantly lower in the rats fed with the high-fat high-sucrose diet. Furthermore, we suggest that the development of increased blood pressure in these rats was attributable to the reduced NOS activity and then to decreased NO production. The observed decrease in the NOS activity in vascular tissues suggests a possible endothelial dysfunction in the rats fed with a high-fat high-sucrose diet. These results are similar to other recent findings; the protein expression of endothelial NOS (eNOS) was lower in hyperlipidemic rats, 9) hypercholesterolemic pigs, 10) and cells exposed to triacylglycerol-mediated oxidative stress. 11) In respect of the effect of flavonoids, we showed that quercetin was effective for depressing lipid peroxidation and suppressing the decrease in NO metabolites in the plasma and urine of rats fed with a high-fat high-sucrose diet. These results suggest the possibility that the effect of quercetin on suppressing the elevation of blood pressure might have come from an increase in NO availability due to its antioxidative activity. Furthermore, we showed that quercetin was effective for increasing the NOS activity in the vascular tissues of rats fed with a high-fat high-sucrose diet. These results suggest that another cause of the effect of quercetin on suppressing the elevation of blood pressure might have come from the increased NOS activity and subsequent suppression of the decrease in NO production in these rats. Several reports have recently suggested that antioxidative vitamins were effective for protecting NOS activity by preventing the NOS protein modulation from oxidation 10) and by preventing the depletion of NOS cofactor tetrahydrobiopterin (BH 4 ). 28 ) BH 4 is a tightly bound cofactor of NOS, and the absence of BH 4 is known to lead to uncoupling of the L-arginine-NO pathway and then causing superoxide formation instead of NO formation. 29) Although we did not identify the precise mechanism whereby quercetin prevented the decrease in NOS activity in the vascular tissues in this experiment, the possibility that the antioxidative activity of quercetin might be effective for protecting the NOS protein and its cofactor BH 4 from oxidative stress could be assumed.
The vasoconstrictor, angiotensin II, is also important in blood pressure control, and the effect of quercetin on decreasing angiotensin II production is another possible mechanism for suppressing the elevation of blood pressure. A recent study has demonstrated enhanced angiotensinogen gene expression in adipose tissue and a high concentration of angiotensin II in the plasma of rats and mice. 30, 31) These results suggest that adiposederived angiotensinogen could contribute to plasma angiotensin II, and then to blood pressure. Although we have not been able to find any reports showing the suppression of angiotensin II production by quercetin, the significant decrease in the weight of adipose tissue may have caused the suppressed angiotensin II prodution in the rats fed with the diet containing 0.5% quercetin. Furthermore, we cannot exclude the possibility that quercetin might be a potent angiotensinconverting enzyme inhibitor. Further studies are needed to elucidate whether quercetin would be effective for suppressing angiotensin II production.
In summary, we have demonstrated that quercetin suppressed the elevation of blood pressure in normotensive rats fed with the high-fat high-sucrose diets. The effective dietary levels of quercetin were 0.02, 0.07, 0.2, and 0.5%, the level of 0.5% being much more effective than the other levels. The increased NO availability caused by the elevated NOS activity, and the antioxidative activity, in the rats fed with quercetin is suggested to be one of the causes of the suppressed elevation of blood pressure.
